Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
2026-09-01

Regulatory Watch

AI-synthesized intelligence from CBN, FIRS, CAC, NAFDAC, SON, and NEPZA — so your business stays ahead of regulatory change.

September 1, 2026 6 updates 2 sources
NAFDAC has issued multiple alerts and a blacklisting notice concerning substandard, falsified, and counterfeit products, as well as safety risks from certain drug combinations. These actions signal heightened regulatory scrutiny in the pharmaceutical and consumer goods sectors, urging businesses to verify product authenticity and ensure compliance to avoid penalties.
What's being regulated
Pharmaceuticals Consumer Goods Healthcare Import/Export Agriculture
Latest regulatory changes
Public Notice on Blacklisting Ayrtons Saunders Ltd, Uk
NAFDAC
NAFDAC blacklists Ayrtons Saunders Ltd, UK, and informs stakeholders of the action.
Businesses dealing with this company's products must cease transactions and remove them from supply chains to avoid regulatory action.
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
NAFDAC
NAFDAC places products marketed by Mofus Nigeria Ltd on a watchlist pending investigation.
Distributors and retailers should verify the status of these products and prepare for potential recalls or restrictions.
Public Alert No. 042/2026-Alert on the Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC alerts on the seizure of suspected substandard and falsified antimalarial medicine.
Pharmacies and healthcare providers must check stock for this specific product and report any suspicious batches to NAFDAC.
Public Alert No. 041/2026 – Alert on Suspected Counterfeit ORACIRE+ Toothpaste
NAFDAC
NAFDAC warns of counterfeit ORACIRE+ toothpaste being distributed as ORACARE+.
Retailers and consumers should verify product authenticity and report any counterfeit items to NAFDAC.
Public Alert No: 039/2026 – Alert on the Risk of Drug Poisoning Associated with Concurrent Use of Gabapentinoids and Other Medicines
NAFDAC
NAFDAC warns of increased drug poisoning risk when gabapentinoids are used with certain other medicines.
Healthcare professionals and patients should be cautious with these drug combinations; pharmacies should provide appropriate counseling.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
Guide on registering fish farms with NEPC for export purposes.
Fish farmers and exporters should follow the guide to ensure compliance and access export opportunities.
What this means for your business
Heightened enforcement against substandard and counterfeit products.
Increased scrutiny on pharmaceutical supply chains.
Need for robust product verification and traceability.
Opportunities for compliant businesses to gain market trust.
Potential for stricter import/export regulations in affected sectors.
What to do next
1 Review product inventories for any items from blacklisted or watchlisted companies.
2 Implement or strengthen quality assurance procedures to detect counterfeit products.
3 Train staff on identifying and reporting substandard or falsified products.
4 Stay updated with NAFDAC alerts and advisories.
5 For fish farmers, follow NEPC registration guidelines to ensure export compliance.
← Previous edition
Browse archive
Next edition →

Never miss a regulatory change

From CBN monetary policy to FIRS tax circulars — our AI Workspace monitors the regulatory landscape so you don't have to.

Create free account